Yoga for Caregivers and Persons With Dementia (YCPD)

February 8, 2024 updated by: Wake Forest University Health Sciences

A Pilot Study Yoga for Caregivers and Persons With Dementia

The purpose of this research is to determine the feasibility and acceptability of yoga classes for persons living with dementia (PLWD) and their care partners. A secondary aim of this study is to examine the impact of yoga on caregiver burden.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Participants will be recruited from the D-Care Study in dyads. Both the caregiver and person with dementia must agree to participate. Screening will be done either in clinics or by telephone in the participants' homes. The intervention will be conducted in community facilities and participants' homes. The sample size will consist of 10 caregiver/person with dementia dyads. This number was chosen to provide evidence of feasibility of conducting yoga classes with dyads.

Study Type

Interventional

Enrollment (Actual)

4

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Winston-Salem, North Carolina, United States, 27157
        • Atrium Health Wake Forest Baptist

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Caregivers: Providing unpaid care to a family member of friend diagnosed Alzheimer's Disease and Alzheimer's Disease Related Dementias (ADRD)
  • Persons with dementia: A diagnosis of dementia; live in the community (assisted living facility is allowed); cognitively able to participate in yoga as determined by study staff

Exclusion Criteria:

  • Non-English-speaking; and practicing yoga or meditation within the last 30 days.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Yoga for Caregivers and Persons With Dementia
Persons With Dementia and their caregivers will participate in up to 20 group yoga classes.
Yoga classes are twice a week for up to 10 weeks with a trained yoga instructor at a location in the community. Classes will last up to 75 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accrual Percentage--Persons with Dementia
Time Frame: Baseline
Number of people randomized/Number of people approached about the study
Baseline
Accrual Percentage--Caregivers
Time Frame: Baseline
Number of people randomized/Number of people approached about the study
Baseline
Percentage Adherence to Intervention Sessions--Persons with Dementia
Time Frame: Week 10
Number of sessions attended/Total number of sessions offered
Week 10
Percentage Adherence to Intervention Sessions--Caregivers
Time Frame: Week 10
Number of sessions attended/Total number of sessions offered
Week 10
Retention Percentage--Persons With Dementia
Time Frame: Week 10
Number of people who complete the Week 10 assessment/Total Number Enrolled
Week 10
Retention Percentage--Caregivers
Time Frame: Week 10
Number of people who complete the Week 10 assessment/Total Number Enrolled
Week 10

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Client Satisfaction Questionnaire--Persons With Dementia
Time Frame: Week 10
8-item measure of satisfaction with the intervention. Scores can range from 8 to 32; higher scores indicate more satisfaction.
Week 10
Client Satisfaction Questionnaire--Caregivers
Time Frame: Week 10
8-item measure of satisfaction with the intervention. Scores can range from 8 to 32; higher scores indicate more satisfaction.
Week 10
Zarit Burden Interview
Time Frame: Baseline, Week 10
Completed by caregiver. 22-item measure of caregiver burden. Scores range from 0 to 88, with higher scores indicating greater caregiver burden.
Baseline, Week 10
Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety--Persons with Dementia
Time Frame: Baseline, Week 10
8-item measure of anxiety symptoms 8-item measure of anxiety symptoms; responses are made on a 5-point Likert scale and converted to t-scores with a mean of 50 and standard deviation of 10; higher scores indicate greater severity of anxiety.
Baseline, Week 10
Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety--Caregivers
Time Frame: Baseline, Week 10
8-item measure of anxiety symptoms 8-item measure of anxiety symptoms; responses are made on a 5-point Likert scale and converted to t-scores with a mean of 50 and SD of 10; higher scores indicate greater severity of anxiety.
Baseline, Week 10
PROMIS Depression--Persons with Dementia
Time Frame: Baseline, Week 10
8-item measure of depressive symptoms; responses are made on a 5-point Likert scale and converted to t-scores with a mean of 50 and SD of 10. higher scores indicate greater severity of depression.
Baseline, Week 10
PROMIS Depression--Caregivers
Time Frame: Baseline, Week 10
8-item measure of depressive symptoms; responses are made on a 5-point Likert scale and converted to t-scores with a mean of 50 and SD of 10. higher scores indicate greater severity of depression.
Baseline, Week 10
PROMIS Self-efficacy for Managing Emotions--Persons with Dementia
Time Frame: Baseline, Week 10
8-item measure of emotional regulation. Responses are made on a 5-point Likert scale and converted to t-scores with a mean of 50 and SD of 10 higher scores indicate greater self-efficacy.
Baseline, Week 10
PROMIS Self-efficacy for Managing Emotions--Caregivers
Time Frame: Baseline, Week 10
8-item measure of emotional regulation. Responses are made on a 5-point Likert scale and converted to t-scores with a mean of 50 and SD of 10 higher scores indicate greater self-efficacy.
Baseline, Week 10
Neuropsychiatric Inventory Questionnaire--Severity
Time Frame: Baseline, Week 10
Completed by caregivers. Severity and distress from 12 care recipient behavioral symptoms. Severity and distress from 12 care recipient behavioral symptoms are rated. Severity is rated on 3 point Likert scale and scores range from 12-36, with higher scores indicating greater severity.
Baseline, Week 10
Neuropsychiatric Inventory Questionnaire--Distress
Time Frame: Baseline, Week 10
Completed by caregivers. Severity and distress from 12 care recipient behavioral symptoms. Severity and distress from 12 care recipient behavioral symptoms are rated. Distress is rated on a 6 point Likert scale and scores range from 0 to 60, with higher scores indicating greater distress
Baseline, Week 10
Insomnia Sleep Index--Persons with Dementia
Time Frame: Baseline, Week 10
7-item self-report measure of type and severity of insomnia symptoms. 7-item measure of type and severity of insomnia symptoms; responses are made on a 5-point Likert scale and summed, with higher scores indicating greater insomnia; scores range from 0 to 28
Baseline, Week 10
Insomnia Sleep Index--Caregivers
Time Frame: Baseline, Week 10
7-item self-report measure of type and severity of insomnia symptoms. 7-item measure of type and severity of insomnia symptoms; responses are made on a 5-point Likert scale and summed, with higher scores indicating greater insomnia; scores range from 0 to 28
Baseline, Week 10

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage Adherence to Independent Practice--Persons With Dementia
Time Frame: Week 10
Number of sessions of independent practice/Total number of recommended independent practice sessions (4X/week)
Week 10
Percentage Adherence to Independent Practice--Caregivers
Time Frame: Week 10
Number of sessions of independent practice/Total number of recommended independent practice sessions (4X/week)
Week 10
Qualitative Questions
Time Frame: Baseline, Week 10
Completed by caregivers. Any changes they noticed, motivation for engaging in yoga, barriers. Interview responses will be reviewed and common themes will be extracted.
Baseline, Week 10
Average Minutes of Yoga Practice per Day--Persons With Dementia
Time Frame: From Baseline through Week 10
Collected from self-reported yoga/stretching log
From Baseline through Week 10
Average Minutes of Yoga Practice per Day--Caregivers
Time Frame: From Baseline through Week 10
Collected from self-reported yoga/stretching log
From Baseline through Week 10

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gretchen Brenes, PhD, Wake Forest University Health Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 2, 2022

Primary Completion (Actual)

August 4, 2022

Study Completion (Actual)

August 4, 2022

Study Registration Dates

First Submitted

October 21, 2021

First Submitted That Met QC Criteria

October 21, 2021

First Posted (Actual)

November 2, 2021

Study Record Updates

Last Update Posted (Estimated)

February 13, 2024

Last Update Submitted That Met QC Criteria

February 8, 2024

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Gentle Yoga

Subscribe